- Home
- STRK vs MRK Comparison
STRK vs MRK Comparison
Compare STRK & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRK
- MRK
- Stock Information
- Founded
- STRK 1989
- MRK 2000
- Country
- STRK United States
- MRK United States
- Employees
- STRK 1534
- MRK N/A
- Industry
- STRK
- MRK Biotechnology: Pharmaceutical Preparations
- Sector
- STRK
- MRK Health Care
- Exchange
- STRK NYSE
- MRK Nasdaq
- Market Cap
- STRK N/A
- MRK 218.2B
- IPO Year
- STRK N/A
- MRK N/A
- Fundamental
- Price
- STRK $85.15
- MRK $78.00
- Analyst Decision
- STRK
- MRK Buy
- Analyst Count
- STRK 0
- MRK 15
- Target Price
- STRK N/A
- MRK $119.86
- AVG Volume (30 Days)
- STRK 527.6K
- MRK 19.8M
- Earning Date
- STRK 04-30-2025
- MRK 04-24-2025
- Dividend Yield
- STRK N/A
- MRK 4.16%
- EPS Growth
- STRK N/A
- MRK 4714.29
- EPS
- STRK N/A
- MRK 6.74
- Revenue
- STRK $463,456,000.00
- MRK $64,168,000,000.00
- Revenue This Year
- STRK N/A
- MRK $2.41
- Revenue Next Year
- STRK N/A
- MRK $6.31
- P/E Ratio
- STRK N/A
- MRK $11.57
- Revenue Growth
- STRK N/A
- MRK 6.74
- 52 Week Low
- STRK $79.25
- MRK $75.93
- 52 Week High
- STRK $95.00
- MRK $134.63
- Technical
- Relative Strength Index (RSI)
- STRK N/A
- MRK 33.43
- Support Level
- STRK N/A
- MRK $75.93
- Resistance Level
- STRK N/A
- MRK $80.02
- Average True Range (ATR)
- STRK 0.00
- MRK 3.36
- MACD
- STRK 0.00
- MRK -0.58
- Stochastic Oscillator
- STRK 0.00
- MRK 14.44
About STRK MICROSTRATEGY 8.00% SERIES A PERPETUAL STRIKE PFD
Strategy is a bitcoin treasury company and a provider of business intelligence services. It is designed to provide investors varying degrees of economic exposure to Bitcoin by offering a range of securities, including equity and fixed-income instruments. The company also provide industry AI-powered enterprise analytics software.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.